Study Attribute | Value |
---|---|
CEBS Accession Number: | 002-02044-0002-0000-4 |
Chemical Name: | Diglycidyl resorcinol ether (DGRE) |
CASRN: | 101-90-6 |
NTP Study Type: | Genetic Toxicology - Mammalian Cell Cytogenetics |
NTP Study ID: | 120506_CA |
Study Result: | Positive |
Activation | Trial | Trial Call |
---|---|---|
No Activation | 1 | Positive |
Induced Rat Liver S9 | 1_S9 | Weakly Positive* |
No Activation | 2 | Positive |
Induced Rat Liver S9 | 2_S9 | Weakly Positive* |
Dose µg/mL | Total Cells Examined | Total Aberrations | Complex Aberrations | Simple Aberrations | Other Abs | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
No. of Abs | Abs Per Cell | % Cells With Abs | No. of Abs. | Abs Per Cell | % Cells With Abs | No. of Abs. | Abs Per Cell | % Cells With Abs | No. of Abs. | Abs Per Cell | % Cells With Abs | ||||
Vehicle Control: | Negative (Not Specified) | 0 | 100 | 2 | 0.020 | 2.0 | 1 | 0.010 | 1.0 | 1 | 0.010 | 1.0 | 0 | 0.000 | 0.0 |
Dimethyl Sulfoxide | 0 | 100 | 0 | 0.000 | 0.0 | 0 | 0.000 | 0.0 | 0 | 0.000 | 0.0 | 0 | 0.000 | 0.0 | |
Test Chemical: | Diglycidyl resorcinol ether (DGRE) | 0.5 | 100 | 5 | 0.050 | 5.0 | 3 | 0.030 | 3.0 | 2 | 0.020 | 2.0 | 0 | 0.000 | 0.0 |
1.6 | 100 | 6 | 0.060 | 6.0 | 2 | 0.020 | 2.0 | 4 | 0.040 | 4.0 | 0 | 0.000 | 0.0 | ||
5 | 100 | 66 | 0.660 | 40.0 | 28 | 0.280 | 22.0 | 28 | 0.280 | 21.0 | 10 | 0.100 | 1.0 | ||
16 | 100 | 149 | 1.490 | 69.0 | 44 | 0.440 | 34.0 | 95 | 0.950 | 51.0 | 10 | 0.100 | 1.0 | ||
25 | 0 | 0 | 0.000 | 0.0 | 0 | 0.000 | 0.0 | 0 | 0.000 | 0.0 | 0 | 0.000 | 0.0 | ||
Positive Control: | Mitomycin-C | 0.125 | 100 | 17 | 0.170 | 14.0 | 9 | 0.090 | 7.0 | 8 | 0.080 | 8.0 | 0 | 0.000 | 0.0 |
Mitomycin-C | 1 | 50 | 29 | 0.580 | 48.0 | 15 | 0.300 | 28.0 | 14 | 0.280 | 28.0 | 0 | 0.000 | 0.0 | |
Trend: | 12.919 | 8.474 | 10.656 | ||||||||||||
Probability: | 0.000 | 0.000 | 0.000 |
Dose µg/mL | Total Cells Examined | Total Aberrations | Complex Aberrations | Simple Aberrations | Other Abs | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
No. of Abs | Abs Per Cell | % Cells With Abs | No. of Abs. | Abs Per Cell | % Cells With Abs | No. of Abs. | Abs Per Cell | % Cells With Abs | No. of Abs. | Abs Per Cell | % Cells With Abs | ||||
Vehicle Control: | Negative (Not Specified) | 0 | 100 | 3 | 0.030 | 3.0 | 1 | 0.010 | 1.0 | 2 | 0.020 | 2.0 | 0 | 0.000 | 0.0 |
Dimethyl Sulfoxide | 0 | 100 | 3 | 0.030 | 3.0 | 1 | 0.010 | 1.0 | 1 | 0.010 | 1.0 | 1 | 0.010 | 1.0 | |
Test Chemical: | Diglycidyl resorcinol ether (DGRE) | 5 | 100 | 5 | 0.050 | 5.0 | 1 | 0.010 | 1.0 | 3 | 0.030 | 3.0 | 1 | 0.010 | 1.0 |
16 | 100 | 8 | 0.080 | 8.0 | 7 | 0.070 | 7.0 | 1 | 0.010 | 1.0 | 0 | 0.000 | 0.0 | ||
25 | 100 | 7 | 0.070 | 6.0 | 3 | 0.030 | 3.0 | 4 | 0.040 | 4.0 | 0 | 0.000 | 0.0 | ||
50 | 100 | 33 | 0.330 | 27.0 | 16 | 0.160 | 14.0 | 17 | 0.170 | 15.0 | 0 | 0.000 | 0.0 | ||
Positive Control: | Cyclophosphamide | 15 | 100 | 25 | 0.250 | 21.0 | 15 | 0.150 | 12.0 | 10 | 0.100 | 10.0 | 0 | 0.000 | 0.0 |
Cyclophosphamide | 50 | 50 | 27 | 0.540 | 40.0 | 14 | 0.280 | 22.0 | 13 | 0.260 | 22.0 | 0 | 0.000 | 0.0 | |
Trend: | 4.977 | 4.012 | 3.912 | ||||||||||||
Probability: | 0.000 | 0.000 | 0.000 |
Dose µg/mL | Total Cells Examined | Total Aberrations | Complex Aberrations | Simple Aberrations | Other Abs | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
No. of Abs | Abs Per Cell | % Cells With Abs | No. of Abs. | Abs Per Cell | % Cells With Abs | No. of Abs. | Abs Per Cell | % Cells With Abs | No. of Abs. | Abs Per Cell | % Cells With Abs | ||||
Vehicle Control: | Negative (Not Specified) | 0 | 100 | 0 | 0.000 | 0.0 | 0 | 0.000 | 0.0 | 0 | 0.000 | 0.0 | 0 | 0.000 | 0.0 |
Dimethyl Sulfoxide | 0 | 100 | 3 | 0.030 | 3.0 | 0 | 0.000 | 0.0 | 3 | 0.030 | 3.0 | 0 | 0.000 | 0.0 | |
Test Chemical: | Diglycidyl resorcinol ether (DGRE) | 0.5 | 100 | 1 | 0.010 | 1.0 | 1 | 0.010 | 1.0 | 0 | 0.000 | 0.0 | 0 | 0.000 | 0.0 |
1.6 | 100 | 4 | 0.040 | 4.0 | 3 | 0.030 | 3.0 | 1 | 0.010 | 1.0 | 0 | 0.000 | 0.0 | ||
5 | 100 | 17 | 0.170 | 14.0 | 7 | 0.070 | 6.0 | 10 | 0.100 | 9.0 | 0 | 0.000 | 0.0 | ||
16 | 100 | 153 | 1.530 | 61.0 | 46 | 0.460 | 32.0 | 64 | 0.640 | 38.0 | 43 | 0.430 | 7.0 | ||
50 | 0 | 0 | 0.000 | 0.0 | 0 | 0.000 | 0.0 | 0 | 0.000 | 0.0 | 0 | 0.000 | 0.0 | ||
Positive Control: | Mitomycin-C | 0.25 | 100 | 33 | 0.330 | 26.0 | 11 | 0.110 | 11.0 | 22 | 0.220 | 17.0 | 0 | 0.000 | 0.0 |
Mitomycin-C | 1 | 50 | 25 | 0.500 | 44.0 | 12 | 0.240 | 22.0 | 13 | 0.260 | 24.0 | 0 | 0.000 | 0.0 | |
Trend: | 10.969 | 7.871 | 8.257 | ||||||||||||
Probability: | 0.000 | 0.000 | 0.000 |
Dose µg/mL | Total Cells Examined | Total Aberrations | Complex Aberrations | Simple Aberrations | Other Abs | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
No. of Abs | Abs Per Cell | % Cells With Abs | No. of Abs. | Abs Per Cell | % Cells With Abs | No. of Abs. | Abs Per Cell | % Cells With Abs | No. of Abs. | Abs Per Cell | % Cells With Abs | ||||
Vehicle Control: | Negative (Not Specified) | 0 | 100 | 4 | 0.040 | 4.0 | 1 | 0.010 | 1.0 | 3 | 0.030 | 3.0 | 0 | 0.000 | 0.0 |
Dimethyl Sulfoxide | 0 | 100 | 3 | 0.030 | 3.0 | 2 | 0.020 | 2.0 | 1 | 0.010 | 1.0 | 0 | 0.000 | 0.0 | |
Test Chemical: | Diglycidyl resorcinol ether (DGRE) | 5 | 100 | 3 | 0.030 | 3.0 | 2 | 0.020 | 2.0 | 1 | 0.010 | 1.0 | 0 | 0.000 | 0.0 |
16 | 100 | 12 | 0.120 | 10.0 | 4 | 0.040 | 4.0 | 8 | 0.080 | 8.0 | 0 | 0.000 | 0.0 | ||
50 | 100 | 99 | 0.990 | 58.0 | 42 | 0.420 | 34.0 | 57 | 0.570 | 37.0 | 0 | 0.000 | 0.0 | ||
160 | 0 | 0 | 0.000 | 0.0 | 0 | 0.000 | 0.0 | 0 | 0.000 | 0.0 | 0 | 0.000 | 0.0 | ||
Positive Control: | Cyclophosphamide | 15 | 100 | 14 | 0.140 | 13.0 | 4 | 0.040 | 4.0 | 10 | 0.100 | 9.0 | 0 | 0.000 | 0.0 |
Cyclophosphamide | 50 | 50 | 32 | 0.640 | 36.0 | 11 | 0.220 | 20.0 | 11 | 0.220 | 22.0 | 10 | 0.200 | 1.0 | |
Trend: | 9.880 | 7.128 | 7.969 | ||||||||||||
Probability: | 0.000 | 0.000 | 0.000 |